Effects of mild obesity on outcomes in Japanese patients with COVID-19: a nationwide consortium to investigate COVID-19 host genetics.

Ho LeeShotaro ChubachiHo NamkoongHiromu TanakaShiro OtakeKensuke NakagawaraAtsuho MoritaTakahiro FukushimaMayuko WataseTatsuya KusumotoKatsunori MasakiHirofumi KamataMakoto IshiiNaoki HasegawaNorihiro HaradaTetsuya UedaSoichiro UedaTakashi IshiguroKen ArimuraFukuki SaitoTakashi YoshiyamaYasushi NakanoYoshikazu MutohYusuke SuzukiKoji MurakamiYukinori OkadaRyuji KoikeYuko KitagawaAkinori KimuraSeiya ImotoSatoru MiyanoSeishi OgawaTakanori KanaiKoichi Fukunaganull null

Published in: Nutrition & diabetes (2022)

Obesity is a risk factor for respiratory failure in Japanese patients with COVID-19, regardless of the degree of obesity. However, it may not cause severe COVID-19 in a dose-response relationship with BMI. COVID-19 patients with mild obesity may benefit from aggressive intensive care.

Keyphrases

insulin resistance
coronavirus disease
metabolic syndrome
weight loss
weight gain
sars cov
high fat diet induced
type diabetes
respiratory failure
body mass index
adipose tissue
early onset
intensive care unit
physical activity
glycemic control
drug induced